Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy

BACKGROUND: Although concurrent chemoradiotherapy (CRT), as one of the most effective antineoplastic therapies in clinic, can successfully inhibit the growth of tumor cells, a risk of developing secondary tumor is still an insurmountable barrier in clinical practice. RESULTS: Herein, a new platinum...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wei, Wei, Lulu, Chen, Bing, Luo, Xingyu, Xu, Peipei, Cai, Jianfeng, Hu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917711/
https://www.ncbi.nlm.nih.gov/pubmed/35279133
http://dx.doi.org/10.1186/s12951-022-01322-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917711/
https://www.ncbi.nlm.nih.gov/pubmed/35279133
http://dx.doi.org/10.1186/s12951-022-01322-y

Ejemplares similares